Jones Financial Companies
DTIL icon

Jones Financial Companies’s Precision BioSciences DTIL Stock Holding History

Jones Financial Companies’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78 Hold
13
– – ﹤0.01% 4651
2025
Q4 		$54 Sell
13
-127
-91% -$721 ﹤0.01% 4339
2025
Q3 		$708 Buy
140
+70
+100% +$335 ﹤0.01% 3966
2025
Q2 		$301 Buy
+70
New +$345 ﹤0.01% 3869

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies's DTIL Position: Q1 2026 in Review

Jones Financial Companies held its Precision BioSciences (DTIL) position steady in Q1 2026 at 13 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #4651.

Jones Financial Companies first reported a position in DTIL in Q2 2025 and has held it in 4 quarters since. The position peaked at $708 in Q3 2025. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Jones Financial Companies held 13 shares of Precision BioSciences worth $78 as of Q1 2026.
  • Jones Financial Companies left its Precision BioSciences share count unchanged in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4651 holding.
  • Jones Financial Companies first reported a position in Precision BioSciences in Q2 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Precision BioSciences position peaked at $708 in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.